<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">r-n-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский неврологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian neurological journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2658-7947</issn><issn pub-type="epub">2686-7192</issn><publisher><publisher-name>МИА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2658-7947-2020-25-5-4-13</article-id><article-id custom-type="elpub" pub-id-type="custom">r-n-j-115</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEW</subject></subj-group></article-categories><title-group><article-title>Диагностика церебральной амилоидной ангиопатии: на пути к Бостонским критериям 2.0</article-title><trans-title-group xml:lang="en"><trans-title>Diagnostics of cerebral amyloid angiopathy: the way to Boston criteria 2.0</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0749-3827</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новосадова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Novosadova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">novosadova_o_a@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6061-8118</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулеш</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulesh</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">aleksey.kulesh@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6256-3429</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григорьева</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigoryeva</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">vrgr@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Приволжский исследовательский медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Пермский государственный медицинский университет им. академика Е.А. Вагнера» Минздрава России;&#13;
ГАУЗ ПК «Городская клиническая больница №4», 614107, Пермь, Россия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E.A.Vagner Perm State Medical University;&#13;
City Clinical Hospital №4</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2020</year></pub-date><volume>25</volume><issue>5</issue><fpage>4</fpage><lpage>13</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Новосадова О.А., Кулеш А.А., Григорьева В.Н., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Новосадова О.А., Кулеш А.А., Григорьева В.Н.</copyright-holder><copyright-holder xml:lang="en">Novosadova O.A., Kulesh A.A., Grigoryeva V.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.r-n-j.com/jour/article/view/115">https://www.r-n-j.com/jour/article/view/115</self-uri><abstract><p>В статье обсуждаются нейровизуализационные проявления церебральной амилоидной ангиопатии — заболевания, ассоциированного с долевыми внутримозговыми кровоизлияниями, конвекситальными субарахноидальными кровоизлияниями у пожилых пациентов, транзиторными фокальными неврологическими эпизодами и когнитивными расстройствами. Представлена характеристика маркеров, которые в настоящее время рассматриваются для  включения в  Бостонские диагностические  критерии 2.0. Они  представлены двумя группами: геморрагические, к которым относятся внутримозговые кровоизлияния, церебральные микрокровоизлияния, корковый поверхностный сидероз, и негеморрагические, включающие гиперинтенсивность белого вещества, пятна гиперинтенсивности белого вещества и МРТ-видимые периваскулярные пространства в полуовальном центре. Каждый из маркеров подробно описан с точки зрения патогенеза, клинических ассоциаций и проиллюстрирован.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>церебральная амилоидная ангиопатия</kwd><kwd>диагностические критерии</kwd><kwd>магнитно-резонансная томография</kwd><kwd>церебральные микрокровоизлияния</kwd><kwd>корковый поверхностный сидероз</kwd><kwd>периваскулярные пространства</kwd><kwd>гиперинтенсивность белого вещества</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Gang Q., Werring D.J. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J. Neurol. Neurosurg. Psychiatry. 2012;83(2):124–137. https://doi.org/10.1136/jnnp-2011-301308</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Gang Q., Werring D.J. Sporadic cerebral amyloid angiopathy  revisited:  recent  insights  into  pathophysiology and clinical spectrum. J. Neurol. Neurosurg. Psychiatry. 2012;83(2):124–137. https://doi.org/10.1136/jnnp-2011-301308</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wermer M.J.H., Greenberg S.M. The growing clinical spectrum of cerebral amyloid angiopathy. Current opinion in neurology. 2018;31(1):28–35. https://doi.org/10.1097/WCO.0000000000000510</mixed-citation><mixed-citation xml:lang="en">Wermer M.J.H., Greenberg S.M. The growing clinical spectrum of cerebral  amyloid  angiopathy.  Current  opinion in neurology. 2018;31(1):28–35. https://doi.org/10.1097/WCO.0000000000000510</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кулеш А.А. Современные подходы к диагностике при внутримозговом кровоизлиянии. Неврология, нейропсихиатрия, психосоматика. 2020;12(2):4–11.. https://doi.org/10.14412/2074-2711-2020-2-4-11</mixed-citation><mixed-citation xml:lang="en">Kulesh A.A. Current approaches to diagnosing in intracerebral hemorrhage. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):4–11. (In Russian). https://doi.org/10.14412/2074-2711-2020-2-4-11</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кулеш А.А., Шестаков В.В. Сосудистые недементные когнитивные нарушения: диагноз, прогноз, лечение и профилактика. Неврология, нейропсихиатрия, психосоматика. 2017;9(3):68–75. https://doi.org/10.14412/2074-2711-2017-3-68-75</mixed-citation><mixed-citation xml:lang="en">Kulesh A.A., Shestakov V.V. Vascular cognitive impairment, no dementia: diagnosis, prognosis, treatment, and prevention. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):68–75. (In Russian). https://doi.org/10.14412/2074-2711-2017-3-68-75</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Кулеш А.А., Горст Н.Х., Кузина Е.В., Дробаха В.Е., Шестаков В.В., Каракулова Ю.B. Амилоидный ангиит и прогрессирующий корковый поверхностный сидероз как агрессивные фенотипы церебральной амилоидной ангиопатии: принципы рационального ведения пациентов. Российский неврологический журнал. 2019;24(6):29–38. https://doi.org/10.30629/2658-7947-2019-24-6-29-38</mixed-citation><mixed-citation xml:lang="en">Kulesh A.A., Gorst N.K., Kuzina N.V., Drobakha V.E., Shestakov V.V., Karakulova Yu.V. Amyloid angiitis and progressive cortical superﬁcial siderosis as aggressive phenotypes of cerebral amyloid angiopathy: principles of rational management. Russian neurological journal. 2019;24(6):29–38. (In Russian). https://doi.org/10.30629/2658-7947-2019-24-6-29-38</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Greenberg S.M., Al-Shahi Salman R., Biessels G.J., van Buchem M., Cordonnier C., Lee J.M. et al. Outcome markers for clinical trials in cerebral amyloid angiopathy. The Lancet. Neurology. 2014;13(4):419–428. https://doi.org/10.1016/S14744422(14)70003-1</mixed-citation><mixed-citation xml:lang="en">Greenberg S.M., Al-Shahi Salman R., Biessels G.J., van Buchem M., Cordonnier C., Lee J.M. et al. Outcome markers for clinical trials in cerebral amyloid angiopathy. The Lancet. Neurology. 2014;13(4):419–428. https://doi.org/10.1016/S14744422(14)70003-1</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Greenberg S.M., Charidimou A. Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria. Stroke. 2018;49(2):491–497. https://doi.org/10.1161/STROKEAHA.117.016990</mixed-citation><mixed-citation xml:lang="en">Greenberg   S.M.,   Charidimou   A.   Diagnosis   of    Cerebral Amyloid Angiopathy: Evolution of the  Boston  Criteria. Stroke. 2018;49(2):491–497. https://doi.org/10.1161/STROKEAHA.117.016990</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Knudsen K.A., Rosand J., Karluk D., Greenberg S.M. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56(4):537–539. https://doi.org/10.1212/wnl.56.4.537</mixed-citation><mixed-citation xml:lang="en">Knudsen K.A., Rosand J., Karluk D., Greenberg S.M. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56(4):537–539. https://doi.org/10.1212/wnl.56.4.537</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Linn J., Halpin A., Demaerel P., Ruhland J., Giese A.D., Dichgans M. et al. Prevalence of superﬁcial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74(17):1346– 1350. https://doi.org/10.1212/WNL.0b013e3181dad605</mixed-citation><mixed-citation xml:lang="en">Linn J., Halpin A., Demaerel P., Ruhland J., Giese A.D., Dichgans M. et al. Prevalence of superﬁcial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74(17):1346– 1350. https://doi.org/10.1212/WNL.0b013e3181dad605</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Jaunmuktane Z., Baron J.C., Burnell M., Varlet P., Peeters A. et al. White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology. 2014;82(1):57–62. https://doi.org/10.1212/01.wnl.0000438225.02729.04</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Jaunmuktane Z., Baron J.C., Burnell M., Varlet P., Peeters A. et al. White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology. 2014;82(1):57–62. https://doi.org/10.1212/01.wnl.0000438225.02729.04</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez-Ramirez S., Romero J.R., Shoamanesh A., McKee A.C., van Etten E., Pontes-Neto O. et al. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage. Alzheimers Dement. 2015;11(12):1480–1488. https://doi.org/10.1016/j.jalz.2015.04.009</mixed-citation><mixed-citation xml:lang="en">Martinez-Ramirez S., Romero J.R., Shoamanesh A., McKee A.C., van Etten E., Pontes-Neto O. et al. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage. Alzheimers Dement. 2015;11(12):1480–1488. https://doi.org/10.1016/j.jalz.2015.04.009</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Frosch M.P., Al-Shahi Salman R., Baron J.C., Cordonnier C., Hernandez-Guillamon M. et al. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0. Int. J. Stroke. 2019;14(9):956–971. https://doi.org/10.1177/1747493019855888</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Frosch M.P., Al-Shahi Salman R., Baron J.C., Cordonnier C., Hernandez-Guillamon M. et al. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0. Int. J. Stroke. 2019;14(9):956–971. https://doi.org/10.1177/1747493019855888</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. https://doi.org/10.1016/S1474-4422(13)70124-8</mixed-citation><mixed-citation xml:lang="en">Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. https://doi.org/10.1016/S1474-4422(13)70124-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Кулеш А.А., Дробаха В.Е., Шестаков В.В. Геморрагические проявления церебральной амилоидной ангиопатии — от патогенеза к клиническому значению. Неврология, нейропсихиатрия, психосоматика. 2018;10(3):4–11. https://doi.org/10.14412/2074-2711-2018-3-4-11</mixed-citation><mixed-citation xml:lang="en">Kulesh A.A., Drobakha V.E., Shestakov V.V.  Hemorrhagic  manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical signiﬁcance. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4–11. (In Russian). https://doi.org/10.14412/2074-2711-2018-3-4-11</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Schmitt A., Wilson D., Yakushiji Y., Gregoire S.M., Fox Z. et al. The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): Development and assessment of reliability. J. Neurol. Sci. 2017;372:178–183. https://doi.org/10.1016/j.jns.2016.11.021</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Schmitt A., Wilson D., Yakushiji Y.,  Gregoire S.M., Fox Z. et al. The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): Development and assessment of reliability. J. Neurol. Sci. 2017;372:178–183. https://doi.org/10.1016/j.jns.2016.11.021</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Meretoja A., Strbian D., Putaala J., Curtze S., Haapaniemi E., Mustanoja S. et al. SMASH-U: a proposal for etiologic classiﬁcation of intracerebral hemorrhage. Stroke. 2012;43(10):2592– 2597. https://doi.org/10.1161/STROKEAHA.112.661603</mixed-citation><mixed-citation xml:lang="en">Meretoja A., Strbian D., Putaala J., Curtze S., Haapaniemi E., Mustanoja S. et al. SMASH-U: a proposal for etiologic classiﬁcation of intracerebral hemorrhage. Stroke. 2012;43(10):2592– 2597. https://doi.org/10.1161/STROKEAHA.112.661603</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Martí-Fàbregas J., Prats-Sánchez L., Martínez-Domeño A., Camps-Renom P., Marín R., Jiménez-Xarrié E. et al. The HATOMIC Criteria for the Etiologic Classiﬁcation of Patients with Intracerebral Hemorrhage. PLoS One. 2016;11(6):e0156992. Published 2016 Jun 8. https://doi.org/10.1371/journal.pone.0156992</mixed-citation><mixed-citation xml:lang="en">Martí-Fàbregas J., Prats-Sánchez L., Martínez-Domeño A., Camps-Renom P., Marín R., Jiménez-Xarrié E. et al. The HATOMIC Criteria for the Etiologic Classiﬁcation of Patients with Intracerebral Hemorrhage. PLoS One. 2016;11(6):e0156992. Published 2016 Jun 8. https://doi.org/10.1371/journal.pone.0156992</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rodrigues M.A., Samarasekera N., Lerpiniere C., Humphreys C., McCarron M.O., White P.M. et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018;17(3):232– 240. https://doi.org/10.1016/S1474-4422(18)30006-1</mixed-citation><mixed-citation xml:lang="en">Rodrigues M.A., Samarasekera N., Lerpiniere C., Humphreys C., McCarron M.O., White P.M. et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018;17(3):232– 240. https://doi.org/10.1016/S1474-4422(18)30006-1</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Roh D., Sun C.H., Schmidt J.M., Gurol E., Murthy S., Park Z.S. et al. Primary Intracerebral Hemorrhage: A Closer Look at Hypertension and Cerebral Amyloid Angiopathy. Neurocrit. Care. 2018;29(1):77–83. https://doi.org/10.1007/s12028-018-0514-z</mixed-citation><mixed-citation xml:lang="en">Roh D., Sun C.H., Schmidt J.M., Gurol E., Murthy S., Park Z.S. et al. Primary Intracerebral Hemorrhage: A Closer Look at Hypertension and Cerebral Amyloid Angiopathy. Neurocrit. Care. 2018;29(1):77–83. https://doi.org/10.1007/s12028-018-0514-z</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lin C.M., Arishima H., Kikuta K.I., Naiki H., Kitai R., Kodera T. et al. Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages. J. Neurol. 2018;265(3):567–577. https://doi.org/10.1007/s00415-018-8740-z</mixed-citation><mixed-citation xml:lang="en">Lin C.M., Arishima H., Kikuta K.I., Naiki H., Kitai R., Kodera T. et al. Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages. J. Neurol. 2018;265(3):567–577. https://doi.org/10.1007/s00415-018-8740-z</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Imaizumi T., Moulin S., Biﬃ A., Samarasekera N., Yakushiji Y. et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis. Neurology. 2017;89(8):820–829. https://doi.org/10.1212/WNL.0000000000004259</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Imaizumi T., Moulin S., Biﬃ A., Samarasekera N., Yakushiji Y. et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis. Neurology. 2017;89(8):820–829. https://doi.org/10.1212/WNL.0000000000004259</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">van Etten E.S., Gurol M.E., van der Grond J., Haan J., Viswanathan A., Schwab K.M. et al. Recurrent hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy. Neurology. 2016;87(14):1482–1487. https://doi.org/10.1212/WNL.0000000000003181</mixed-citation><mixed-citation xml:lang="en">van Etten E.S., Gurol M.E., van der Grond J., Haan J., Viswanathan A., Schwab K.M. et al. Recurrent  hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy. Neurology. 2016;87(14):1482–1487. https://doi.org/10.1212/WNL.0000000000003181</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Casolla B., Moulin S., Kyheng M., Hénon H., Labreuche J., Leys D. et al. Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019;50(5):1100– 1107. https://doi.org/10.1161/STROKEAHA.118.024449</mixed-citation><mixed-citation xml:lang="en">Casolla B., Moulin S., Kyheng M., Hénon H., Labreuche J., Leys D. et al. Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019;50(5):1100– 1107. https://doi.org/10.1161/STROKEAHA.118.024449</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Greenberg S.M., Vernooij M.W., Cordonnier C., Viswanathan A., Al-Shahi Salman R., Warach S. et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8(2):165– 174. https://doi.org/10.1016/S1474-4422(09)70013-4</mixed-citation><mixed-citation xml:lang="en">Greenberg S.M., Vernooij M.W., Cordonnier C., Viswanathan A., Al-Shahi Salman R., Warach S. et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8(2):165– 174. https://doi.org/10.1016/S1474-4422(09)70013-4</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pétrault M., Casolla B., Ouk T., Cordonnier C., Bérézowski V. Cerebral microbleeds: Beyond the macroscope. Int. J. Stroke. 2019;14(5):468–475. https://doi.org/10.1177/1747493019830594</mixed-citation><mixed-citation xml:lang="en">Pétrault M., Casolla B., Ouk  T.,  Cordonnier  C., Bérézowski V. Cerebral microbleeds: Beyond the macroscope. Int. J. Stroke. 2019;14(5):468–475. https://doi.org/10.1177/1747493019830594</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Fazekas F., Kleinert R., Roob G., Kleinert G., Kapeller P., Schmidt R. et al. Histopathologic analysis of foci of signal loss on gradientecho T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am. J. Neuroradiol. 1999;20(4):637–642.</mixed-citation><mixed-citation xml:lang="en">Fazekas F., Kleinert R., Roob G., Kleinert G., Kapeller P., Schmidt R. et al. Histopathologic analysis of foci of signal loss on gradientecho T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am. J. Neuroradiol. 1999;20(4):637–642.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Dierksen G.A., Skehan M.E., Khan M.A., Jeng J., Nandigam R.N., Becker J.A. et al. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann. Neurol. 2010;68(4):545–548. https://doi.org/10.1002/ana.22099</mixed-citation><mixed-citation xml:lang="en">Dierksen G.A., Skehan  M.E.,  Khan  M.A.,  Jeng  J., Nandigam R.N., Becker J.A. et al. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann. Neurol. 2010;68(4):545–548. https://doi.org/10.1002/ana.22099</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Graﬀ-Radford J., Botha H., Rabinstein A.A., Gunter J.L., Przybelski S.A., Lesnick T. et al. Cerebralmicrobleeds: Prevalence and relationship to amyloid burden. Neurology. 2019;92(3):e253– e262. https://doi.org/10.1212/WNL.0000000000006780</mixed-citation><mixed-citation xml:lang="en">Graﬀ-Radford J., Botha H., Rabinstein A.A., Gunter J.L., Przybelski S.A., Lesnick T. et al. Cerebralmicrobleeds: Prevalence and relationship to amyloid burden. Neurology. 2019;92(3):e253– e262. https://doi.org/10.1212/WNL.0000000000006780</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">van Veluw S.J., Biessels G.J., Klijn C.J., Rozemuller A.J. Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy. Neurology. 2016;86(9):867–871. https://doi.org/10.1212/WNL.0000000000002419</mixed-citation><mixed-citation xml:lang="en">van Veluw S.J., Biessels G.J., Klijn C.J., Rozemuller A.J. Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy. Neurology. 2016;86(9):867–871. https://doi.org/10.1212/WNL.0000000000002419</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Boulouis G., Gurol M.E., Ayata C., Bacskai B.J., Frosch M.P. et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017;140(7):1829–1850. https://doi.org/10.1093/brain/awx047</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Boulouis G., Gurol M.E., Ayata C., Bacskai B.J., Frosch M.P. et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017;140(7):1829–1850. https://doi.org/10.1093/brain/awx047</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ito A.O., Shindo A., Ii Y., Ishikawa H., Taniguchi A., Shiba M. et al. Small Cortical Infarcts Transformed to Lobar Cerebral Microbleeds: A Case Series. J Stroke Cerebrovasc Dis. 2019;28(4):e30–e32. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.12.050</mixed-citation><mixed-citation xml:lang="en">Ito A.O., Shindo A., Ii Y., Ishikawa H., Taniguchi A., Shiba M. et al. Small Cortical Infarcts Transformed to Lobar Cerebral Microbleeds: A Case Series. J Stroke Cerebrovasc Dis. 2019;28(4):e30–e32. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.12.050</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">van Veluw S.J., Scherlek A.A., Freeze W.M., Ter Telgte A., van der Kouwe A.J., Bacskai B.J. et al. Diﬀerent microvascular alterations underlie microbleeds and microinfarcts. Ann. Neurol. 2019;86(2):279–292. https://doi.org/10.1002/ana.25512</mixed-citation><mixed-citation xml:lang="en">van Veluw S.J., Scherlek A.A., Freeze W.M., Ter Telgte A., van der Kouwe A.J., Bacskai B.J. et al. Diﬀerent microvascular alterations underlie microbleeds and microinfarcts. Ann. Neurol. 2019;86(2):279–292. https://doi.org/10.1002/ana.25512</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Dixon S.J., Stockwell B.R. The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 2014;10(1):9–17. https://doi.org/10.1038/nchembio.1416</mixed-citation><mixed-citation xml:lang="en">Dixon S.J., Stockwell B.R. The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 2014;10(1):9–17. https://doi.org/10.1038/nchembio.1416</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Babu R., Bagley J.H., Di C., Friedman A.H., Adamson C. Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage–induced secondary brain injury and as potential targets for intervention. Neurosurg. Focus. 2012;32(4):E8. https://doi.org/10.3171/2012.1.FOCUS11366</mixed-citation><mixed-citation xml:lang="en">Babu R., Bagley J.H., Di C., Friedman A.H., Adamson C. Thrombin and hemin as  central  factors  in  the  mechanisms of intracerebral hemorrhage–induced secondary brain injury and as potential targets for intervention. Neurosurg. Focus. 2012;32(4):E8. https://doi.org/10.3171/2012.1.FOCUS11366</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Li H.Q., Cai W.J., Hou X.H., Cui M., Tan L., Yu J.T. et al. Genome–Wide Association Study of Cerebral Microbleeds on MRI. Neurotox. Res. 2020;37(1):146–155. https://doi.org/10.1007/s12640–019–00073–3</mixed-citation><mixed-citation xml:lang="en">Li H.Q., Cai W.J., Hou X.H., Cui M., Tan L., Yu J.T. et al. Genome–Wide Association Study of  Cerebral  Microbleeds on MRI. Neurotox. Res. 2020;37(1):146–155. https://doi.org/10.1007/s12640–019–00073–3</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Vernooij M.W., van der Lugt A., Ikram M.A., Wielopolski ZP.A., Niessen W.J., Hofman A. et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208–1214. https://doi.org/10.1212/01.wnl.0000307750.41970.d9</mixed-citation><mixed-citation xml:lang="en">Vernooij M.W., van der Lugt A., Ikram M.A., Wielopolski ZP.A., Niessen W.J., Hofman A. et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208–1214. https://doi.org/10.1212/01.wnl.0000307750.41970.d9</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Haller S., Vernooij M.W., Kuijer J.P.A., Larsson E.M., Jäger H.R., Barkhof F. Cerebral Microbleeds: Imaging and Clinical Signiﬁcance. Radiology. 2018;287(1):11–28. https://doi.org/10.1148/radiol.2018170803</mixed-citation><mixed-citation xml:lang="en">Haller S.,  Vernooij  M.W.,  Kuijer  J.P.A.,  Larsson  E.M., Jäger H.R., Barkhof F. Cerebral Microbleeds: Imaging and Clinical Signiﬁcance. Radiology. 2018;287(1):11–28. https://doi.org/10.1148/radiol.2018170803</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Haller S., Scheﬄer M., Salomir R., Herrmann F.R., Gold G., Montandon M.L. et al. MRI detection of cerebral microbleeds: size matters. Neuroradiology. 2019;61(10):1209–1213. https://doi.org/10.1007/s00234–019–02267–0</mixed-citation><mixed-citation xml:lang="en">Haller S., Scheﬄer M., Salomir R., Herrmann F.R., Gold G., Montandon M.L. et al. MRI detection of cerebral microbleeds: size matters. Neuroradiology. 2019;61(10):1209–1213. https://doi.org/10.1007/s00234–019–02267–0</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Biﬃ A., Halpin A., Towﬁghi A., Gilson A., Busl K., Rost N. et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75(8):693–698. https://doi.org/10.1212/WNL.0b013e3181eee40f</mixed-citation><mixed-citation xml:lang="en">Biﬃ A., Halpin A., Towﬁghi A., Gilson A., Busl K., Rost N. et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75(8):693–698. https://doi.org/10.1212/WNL.0b013e3181eee40f</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Gregoire S.M., Chaudhary U.J., Brown M.M., Yousry T.A., Kallis C., Jäger H.R. et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73(21):1759–1766. https://doi.org/10.1212/WNL.0b013e3181c34a7d</mixed-citation><mixed-citation xml:lang="en">Gregoire S.M., Chaudhary U.J., Brown M.M., Yousry T.A., Kallis C., Jäger H.R. et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73(21):1759–1766. https://doi.org/10.1212/WNL.0b013e3181c34a7d</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Pasi M., Charidimou A., Boulouis G., Auriel E., Ayres A., Schwab K.M. et al. Mixed–location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. Neurology. 2018;90(2):e119–e126. https://doi.org/10.1212/WNL.0000000000004797</mixed-citation><mixed-citation xml:lang="en">Pasi M., Charidimou A., Boulouis G., Auriel E., Ayres A., Schwab K.M. et al. Mixed–location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. Neurology. 2018;90(2):e119–e126. https://doi.org/10.1212/WNL.0000000000004797</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Poels M.M., Vernooij M.W., Ikram M.A., Hofman A., Krestin G.P., van Der Lugt A. et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010;41(10):103–S106. https://doi.org/10.1161/STROKEAHA.110.595181</mixed-citation><mixed-citation xml:lang="en">Poels M.M., Vernooij M.W., Ikram  M.A.,  Hofman  A., Krestin G.P., van Der Lugt A. et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010;41(10):103–S106. https://doi.org/10.1161/STROKEAHA.110.595181</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Caunca M.R., Del Brutto V., Gardener H., Shah N., Dequatre– Ponchelle N., Cheung Y.K. et al. Cerebral Microbleeds., Vascular Risk Factors., and Magnetic Resonance Imaging Markers: The Northern Manhattan Study. J. Am. Heart Assoc. 2016;5(9):e003477. Published 2016 Sep 16. https://doi.org/10.1161/JAHA.116.003477</mixed-citation><mixed-citation xml:lang="en">Caunca M.R., Del Brutto V., Gardener H., Shah N., Dequatre– Ponchelle N., Cheung Y.K. et al. Cerebral Microbleeds., Vascular Risk Factors., and Magnetic Resonance Imaging Markers: The Northern Manhattan Study. J. Am. Heart Assoc. 2016;5(9):e003477. Published 2016 Sep 16. https://doi.org/10.1161/JAHA.116.003477</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Das A.S., Regenhardt R.W., Vernooij M.W., Blacker D., Charidimou A., Viswanathan A. Asymptomatic Cerebral Small Vessel Disease: Insights from Population–Based Studies. J. Stroke. 2019;21(2):121–138. https://doi.org/10.5853/jos.2018.03608</mixed-citation><mixed-citation xml:lang="en">Das A.S., Regenhardt R.W., Vernooij M.W., Blacker D., Charidimou A., Viswanathan A. Asymptomatic Cerebral Small Vessel  Disease:  Insights   from   Population–Based   Studies. J. Stroke. 2019;21(2):121–138. https://doi.org/10.5853/jos.2018.03608</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Graﬀ-Radford J., Botha H., Rabinstein A.A., Gunter J.L., Przybelski S.A., Lesnick T. et al. Cerebral microbleed incidence., relationship to amyloid burden: The Mayo Clinic Study of Aging. Neurology. 2020;94(2):e190–e199. https://doi.org/10.1212/WNL.0000000000008735</mixed-citation><mixed-citation xml:lang="en">Graﬀ-Radford J., Botha H., Rabinstein A.A., Gunter J.L., Przybelski S.A., Lesnick T. et al. Cerebral microbleed incidence., relationship to amyloid burden: The Mayo Clinic Study of Aging. Neurology. 2020;94(2):e190–e199. https://doi.org/10.1212/WNL.0000000000008735</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai H.H., Pasi M., Tsai L.K., Chen Y.F., Chen Y.W., Tang S.C. et al. Superﬁcial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020;51(1):202–208. https://doi.org/10.1161/STROKEAHA.119.026235</mixed-citation><mixed-citation xml:lang="en">Tsai H.H., Pasi M., Tsai L.K., Chen Y.F., Chen Y.W., Tang S.C. et al. Superﬁcial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020;51(1):202–208. https://doi.org/10.1161/STROKEAHA.119.026235</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Gavriliuc P., Molad J., Yaghmour N., Honig A., Gomori J.M., Cohen J.E. et al. Cerebellar hemorrhages in patients with cerebral amyloid angiopathy. J. Neurol. Sci. 2019;405:116418. https://doi.org/10.1016/j.jns.2019.08.003</mixed-citation><mixed-citation xml:lang="en">Gavriliuc P., Molad J., Yaghmour N., Honig A., Gomori J.M., Cohen J.E. et al. Cerebellar hemorrhages in patients with cerebral amyloid angiopathy. J. Neurol. Sci. 2019;405:116418. https://doi.org/10.1016/j.jns.2019.08.003</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Shams S., Romero J.R., Ding J., Veltkamp R., Horstmann S. Clinical signiﬁcance of cerebral microbleeds on MRI: A comprehensive meta–analysis of risk of intracerebral hemorrhage., ischemic stroke., mortality., and dementia in cohort studies (v1). Int. J. Stroke. 2018;13(5):454–468. https://doi.org/10.1177/1747493017751931</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Shams S., Romero J.R., Ding J., Veltkamp R., Horstmann S. Clinical signiﬁcance of cerebral microbleeds on MRI: A comprehensive meta–analysis of risk of intracerebral hemorrhage., ischemic stroke., mortality., and dementia in cohort  studies  (v1).  Int.  J.  Stroke.  2018;13(5):454–468.  https://doi.org/10.1177/1747493017751931</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson D., Ambler G., Shakeshaft C., Brown M.M., Charidimou A., Al-Shahi Salman R. et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial ﬁbrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS–2): a multicentre observational cohort study. Lancet Neurol. 2018;17(6):539–547. https://doi.org/10.1016/S1474–4422(18)30145–5</mixed-citation><mixed-citation xml:lang="en">Wilson D., Ambler G., Shakeshaft C., Brown M.M., Charidimou A., Al-Shahi Salman R. et al. Cerebral microbleeds and intracranial haemorrhage risk in  patients  anticoagulated for atrial ﬁbrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS–2): a multicentre observational cohort study. Lancet Neurol. 2018;17(6):539–547. https://doi.org/10.1016/S1474–4422(18)30145–5</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Tsivgoulis G., Zand R., Katsanos A.H., Turc G., Nolte C.H., Jung S. et al. Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden: A Meta–analysis. JAMA Neurol. 2016;73(6):675–683. https://doi.org/10.1001/jamaneurol.2016.0292</mixed-citation><mixed-citation xml:lang="en">Tsivgoulis G., Zand R., Katsanos A.H., Turc G., Nolte C.H., Jung S. et al. Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden: A Meta–analysis. JAMA Neurol. 2016;73(6):675–683. https://doi.org/10.1001/jamaneurol.2016.0292</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Akoudad S., Wolters F.J., Viswanathan A., Bruijn R.F., van Der Lugt A., Hofman A., Association of Cerebral Microbleeds With Cognitive Decline and Dementia. JAMA Neurol. 2016;73(8):934– 943. https://doi.org/10.1001/jamaneurol.2016.1017</mixed-citation><mixed-citation xml:lang="en">Akoudad S., Wolters F.J., Viswanathan A., Bruijn R.F., van Der Lugt A., Hofman A., Association of Cerebral Microbleeds With Cognitive Decline and Dementia. JAMA Neurol. 2016;73(8):934– 943. https://doi.org/10.1001/jamaneurol.2016.1017</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Moulin S., Cordonnier C. Role of Cerebral Microbleeds for Intracerebral Haemorrhage and Dementia. Curr. Neurol. Neurosci. Rep. 2019;19(8):51. https://doi.org/10.1007/s11910– 019–0969–0</mixed-citation><mixed-citation xml:lang="en">Moulin S., Cordonnier C. Role of Cerebral Microbleeds for Intracerebral Haemorrhage and Dementia. Curr. Neurol. Neurosci. Rep. 2019;19(8):51. https://doi.org/10.1007/s11910– 019–0969–0</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Wollenweber F.A., Opherk C., Zedde M., Catak C., Malik R., Duering M. et al. Prognostic relevance of cortical superﬁcial siderosis in cerebral amyloid angiopathy. Neurology. 2019;92(8):e792–e801. https://doi.org/10.1212/WNL.0000000000006956</mixed-citation><mixed-citation xml:lang="en">Wollenweber  F.A., Opherk  C., Zedde  M.,  Catak  C., Malik R., Duering M. et al. Prognostic relevance of cortical superﬁcial siderosis in  cerebral  amyloid  angiopathy. Neurology. 2019;92(8):e792–e801. https://doi.org/10.1212/WNL.0000000000006956</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Zonneveld H.I., Shams S., Kantarci K., Shoamanesh A., Hilal S. APOE and cortical superﬁcial siderosis in CAA: Meta–analysis and potential mechanisms. Neurology. 2019;93(4):e358–e371. https://doi.org/10.1212/WNL.0000000000007818</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Zonneveld H.I., Shams S., Kantarci K., Shoamanesh A., Hilal S. APOE and cortical superﬁcial siderosis in CAA: Meta–analysis and potential mechanisms. Neurology. 2019;93(4):e358–e371. https://doi.org/10.1212/WNL.0000000000007818</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Catak C., Zedde M., Malik R., Janowitz D., Soric V., Seegerer A. et al. Levels of ß-Amyloid in Patients With Cortical Superﬁcial Siderosis. Front. Neurol. 2019;10:439. Published 2019 Apr 26. https://doi.org/10.3389/fneur.2019.00439</mixed-citation><mixed-citation xml:lang="en">Catak C., Zedde M., Malik R., Janowitz D., Soric V., Seegerer A. et al. Levels of ß-Amyloid in Patients With Cortical Superﬁcial Siderosis. Front. Neurol. 2019;10:439. Published 2019 Apr 26. https://doi.org/10.3389/fneur.2019.00439</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Boulouis G., Roongpiboonsopit D., Xiong L., Pasi M., Schwab K.M. et al. Cortical superﬁcial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta– analysis. Int. J. Stroke. 2019;14(7):723–733. https://doi.org/10.1177/1747493019830065</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Boulouis G., Roongpiboonsopit D., Xiong L., Pasi M., Schwab K.M. et al. Cortical superﬁcial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta– analysis. Int. J. Stroke. 2019;14(7):723–733. https://doi.org/10.1177/1747493019830065</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Linn J., Vernooij M.W., Opherk C., Akoudad S., Baron J.C. et al. Cortical superﬁcial siderosis: detection and clinical signiﬁcance in cerebral amyloid angiopathy and related conditions. Brain. 2015;138(Pt 8):2126–2139. https://doi.org/10.1093/brain/awv162</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Linn J., Vernooij M.W., Opherk C., Akoudad S., Baron J.C. et al. Cortical superﬁcial siderosis: detection and clinical signiﬁcance in cerebral amyloid angiopathy and related conditions. Brain. 2015;138(Pt 8):2126–2139. https://doi.org/10.1093/brain/awv162</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Кулеш А.А., Дробаха В.Е., Шестаков В.В. Церебральная болезнь мелких сосудов: классификация., клинические проявления., диагностика и особенности лечения. Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):4–17.. https://doi.org/10.14412/2074–2711–2019–3S–4–17</mixed-citation><mixed-citation xml:lang="en">[Kulesh A.A., Drobakha V.E., Shestakov V.V. Cerebral small vessel disease: classiﬁcation., clinical manifestations., diagnosis., and features of treatment. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):4–17. (In Russian). https://doi.org/10.14412/2074–2711–2019–3S–4–17</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Vernooij M.W., Ikram M.A., Hofman A., Krestin G.P., Breteler M.M., van der Lugt A. Superﬁcial siderosis in the general population. Neurology. 2009;73(3):202–205. https://doi.org/10.1212/WNL.0b013e3181ae7c5e</mixed-citation><mixed-citation xml:lang="en">Vernooij M.W., Ikram M.A., Hofman A., Krestin G.P.,  Breteler M.M., van der Lugt A. Superﬁcial siderosis in the general population. Neurology. 2009;73(3):202–205. https://doi.org/10.1212/WNL.0b013e3181ae7c5e</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Pichler M., Vemuri P., Rabinstein A.A., Aakre J., Flemming K.D., Brown R.D. Jr. et al. Prevalence and Natural History of Superﬁcial Siderosis: A Population–Based Study. Stroke. 2017;48(12):3210– 3214. https://doi.org/10.1161/STROKEAHA.117.018974</mixed-citation><mixed-citation xml:lang="en">Pichler M., Vemuri P., Rabinstein A.A., Aakre J., Flemming K.D., Brown R.D. Jr. et al. Prevalence and Natural History of Superﬁcial Siderosis: A Population–Based Study. Stroke. 2017;48(12):3210– 3214. https://doi.org/10.1161/STROKEAHA.117.018974</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Ni J., Martinez–Ramirez S., Vashkevich A., Ayres A., Rosand J. Cortical Superﬁcial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy. Cerebrovasc Dis. 2016;41(3–4):156–162. https://doi.org/10.1159/000442299</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Ni J., Martinez–Ramirez S., Vashkevich A., Ayres A., Rosand J. Cortical Superﬁcial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy. Cerebrovasc Dis. 2016;41(3–4):156–162. https://doi.org/10.1159/000442299</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Mendes A., Herrmann F.R., Scheﬄer M., Gabriel G., Sveikata L. Rakotomiaramanana B., Cortical Superﬁcial Siderosis: A Descriptive Analysis in a Memory Clinic Population. J. Alzheimers Dis. 2020;73(4):1467–1479. https://doi.org/10.3233/JAD–190619</mixed-citation><mixed-citation xml:lang="en">Mendes A., Herrmann F.R., Scheﬄer M., Gabriel G., Sveikata L. Rakotomiaramanana B., Cortical Superﬁcial Siderosis: A Descriptive Analysis in a Memory Clinic Population. J. Alzheimers Dis. 2020;73(4):1467–1479. https://doi.org/10.3233/JAD–190619</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Verbeek M.M., Kremer B.P., Rikkert M.O., Van Domburg P.H., Skehan M.E., Greenberg S.M. Cerebrospinal ﬂuid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann. Neurol. 2009;66(2):245–249. https://doi.org/10.1002/ana.21694</mixed-citation><mixed-citation xml:lang="en">Verbeek M.M., Kremer B.P., Rikkert M.O., Van Domburg P.H., Skehan M.E., Greenberg S.M. Cerebrospinal ﬂuid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann. Neurol. 2009;66(2):245–249. https://doi.org/10.1002/ana.21694</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Suda S., Shimoyama T., Suzuki S., Ouchi T., Arakawa M., Aoki J. Prevalence and clinical characteristics of cortical superﬁcial siderosis in patients with acute stroke. J. Neurol. 2017;264:2413– 2419. https://doi.org//10.1007/s00415–017–8646–1</mixed-citation><mixed-citation xml:lang="en">Suda S., Shimoyama T., Suzuki S., Ouchi T., Arakawa M., Aoki J. Prevalence and clinical characteristics of cortical superﬁcial siderosis in patients with acute stroke. J. Neurol. 2017;264:2413– 2419. https://doi.org//10.1007/s00415–017–8646–1</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Wollenweber F.A., Baykara E., Zedde M., Gesierich B., Achmuller M., Jouvent E. Cortical Superﬁcial Siderosis in Diﬀerent Types of Cerebral Small Vessel Disease. Stroke. 2017;48(5):1404–1407. https://doi.org/10.1161/STROKEAHA.117.016833</mixed-citation><mixed-citation xml:lang="en">Wollenweber F.A., Baykara E., Zedde M., Gesierich B., Achmuller  M.,  Jouvent   E.   Cortical   Superﬁcial   Siderosis in Diﬀerent Types of  Cerebral  Small  Vessel  Disease. Stroke. 2017;48(5):1404–1407. https://doi.org/10.1161/STROKEAHA.117.016833</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Boulouis G., Greenberg S.M., Viswanathan A. Cortical superﬁcial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis. Neurology. 2019;93(24):e2192– e2202. https://doi.org/10.1212/WNL.0000000000008590</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Boulouis G., Greenberg S.M., Viswanathan A. Cortical superﬁcial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis. Neurology. 2019;93(24):e2192– e2202. https://doi.org/10.1212/WNL.0000000000008590</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">CharidimouA., Boulouis G., Xiong L., Pasi M., Roongpiboonsopit D., Ayres A. et al. Cortical Superﬁcial Siderosis Evolution. Stroke. 2019;50(4):954–962. https://doi.org/10.1161/STROKEAHA.118.023368</mixed-citation><mixed-citation xml:lang="en">CharidimouA., Boulouis G., Xiong L., Pasi M., Roongpiboonsopit D., Ayres A. et al. Cortical Superﬁcial Siderosis Evolution. Stroke. 2019;50(4):954–962. https://doi.org/10.1161/STROKEAHA.118.023368</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Boulouis G., Roongpiboonsopit D., Auriel E., Pasi M., Haley K. Cortical superﬁcial siderosis multifocality in cerebral amyloid angiopathy: A prospective study. Neurology. 2017;89(21):2128–2135. https://doi.org/10.1212/WNL.0000000000004665</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Boulouis G., Roongpiboonsopit D., Auriel E., Pasi M., Haley K. Cortical superﬁcial siderosis multifocality in cerebral amyloid angiopathy: A prospective study. Neurology. 2017;89(21):2128–2135. https://doi.org/10.1212/WNL.0000000000004665</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Задворнов А.А., Голомидов А.В., Григорьев Е.В. Клиническая патофизиология отека головного мозга (часть 1). Вестник анестезиологии и реаниматологии. 2017;14(3):44–50. https://doi.org/10.21292/2078–5658–2017–14–3–44–50</mixed-citation><mixed-citation xml:lang="en">Zadvornov A.A., Golomidov A.V., Grigoriev E.V. Clinical pathophysiology of cerebral edema (part 1). Messenger of Anesthesiology and Resuscitation. 2017;14(3):44–50. (In Russian). https://doi.org/10.21292/2078–5658–2017–14–3–44–50</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Bouvy W.H., Biessels G.J., Kuijf H.J., Kappelle L.J., Luijten P.R., Zwanenburg J.J. Visualization of perivascular spaces and perforating arteries with 7 T magnetic resonance imaging. Invest. Radiol. 2014;49(5):307–313. https://doi.org/10.1097/RLI.0000000000000027</mixed-citation><mixed-citation xml:lang="en">Bouvy W.H., Biessels G.J., Kuijf  H.J.,  Kappelle  L.J., Luijten P.R., Zwanenburg J.J. Visualization of perivascular spaces and perforating arteries with 7 T magnetic resonance imaging. Invest. Radiol. 2014;49(5):307–313. https://doi.org/10.1097/RLI.0000000000000027</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Plog B.A., Nedergaard M. The Glymphatic System in Central Nervous System Health and Disease: Past., Present., and Future. Annu. Rev. Pathol. 2018;13:379–394. https://doi.org/10.1146/annurev–pathol–051217–111018</mixed-citation><mixed-citation xml:lang="en">Plog B.A., Nedergaard M. The Glymphatic System in Central Nervous System Health and Disease: Past., Present., and Future. Annu. Rev. Pathol. 2018;13:379–394. https://doi.org/10.1146/annurev–pathol–051217–111018</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Francis F., Ballerini L., Wardlaw J.M. Perivascular spaces and their associations with risk factors., clinical disorders and neuroimaging features: A systematic review and meta– analysis. Int. J. Stroke. 2019;14(4):359–371. https://doi.org/10.1177/1747493019830321</mixed-citation><mixed-citation xml:lang="en">Francis F., Ballerini L., Wardlaw J.M.  Perivascular  spaces and their associations with risk factors.,  clinical  disorders and neuroimaging features: A systematic review and meta– analysis. Int. J. Stroke. 2019;14(4):359–371. https://doi.org/10.1177/1747493019830321</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Potter G.M., Doubal F.N., Jackson C.A., Chappell F.M., Sudlow C.L., Dennis M.S. et al. Enlarged perivascular spaces and cerebral small vessel disease. Int. J. Stroke. 2015;10(3):376–381. https://doi.org/10.1111/ijs.12054</mixed-citation><mixed-citation xml:lang="en">Potter G.M., Doubal F.N., Jackson C.A., Chappell F.M., Sudlow C.L., Dennis M.S. et al. Enlarged perivascular spaces and cerebral small vessel disease. Int. J. Stroke. 2015;10(3):376–381. https://doi.org/10.1111/ijs.12054</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Boulouis G., Pasi M., Auriel E., van Etten E.S., Haley K. et al. MRI–visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2017;88(12):1157–1164. https://doi.org/10.1212/WNL.0000000000003746</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Boulouis G., Pasi M., Auriel E., van Etten E.S., Haley K. et al. MRI–visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2017;88(12):1157–1164. https://doi.org/10.1212/WNL.0000000000003746</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Новосадова О.А., Григорьева В.Н. Церебральная амилоидная ангиопатия и гипертензивная церебральная микроангиопатия. Дифференциальный диагноз. Неврологический вестник. 2019;I(2):72–79.. https://doi.org/10.17816/nb15666</mixed-citation><mixed-citation xml:lang="en">Novosadova О.А., Grigorjeva V.N. Cerebral amyloid angiopathy and hypertensive cerebral microangiopathy. Diﬀerential diagnosis. Neurology Bulletin. 2019;I(2):72–79. (In Russian). https://doi.org/10.17816/nb15666</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Семенова Т.Н., Новосадова О.А., Григорьева В.Н. Клинико-нейровизуализационные сопоставления ишемических лакунарных инсультов у больных с вероятной церебральной амилоидной ангиопатией и гипертензивной церебральной микроангиопатией. Практическая медицина. 2019;17(7):100–106. https://doi.org/10.32000/2072–1757–2019–7–100–106</mixed-citation><mixed-citation xml:lang="en">Semenova T.N., Novosadova O.A., Grigoreva V.N. Clinical and neuroimaging comparisons of ischemic lacunar strokes in patients with probable cerebral amyloid angiopathy and hypertensive cerebral microangiopathy.  Practical Medicine. 2019;17(7):100–106. (In Russian). https://doi.org/10.32000/2072–1757–2019–7–100–106</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Pantoni L., Love S. The concept of sporadic cerebral small vessel disease: A road map on key deﬁnitions and current concepts. Int. J. Stroke. 2016;11(1):6–18. https://doi.org/10.1177/1747493015607485</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Pantoni L., Love S. The concept of sporadic cerebral small vessel disease: A road map on key deﬁnitions and current concepts. Int. J. Stroke. 2016;11(1):6–18. https://doi.org/10.1177/1747493015607485</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Keable A., Fenna K., Yuen H.M., Johnston D.A., Smyth N.R., Smith C. et al. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim. Biophys. Acta. 2016;1862(5):1037–1046. https://doi.org/10.1016/j.bbadis.2015.08.024</mixed-citation><mixed-citation xml:lang="en">Keable A., Fenna K., Yuen H.M., Johnston D.A., Smyth N.R., Smith C. et al. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral  amyloid  angiopathy.  Biochim.  Biophys. Acta. 2016;1862(5):1037–1046. https://doi.org/10.1016/j.bbadis.2015.08.024</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Boulouis G., Charidimou A., Pasi M., Roongpiboonsopit D., Xiong L., Auriel E. et al. Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: Comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers. J. Neurol. Sci. 2017;380:64–67. https://doi.org/10.1016/j.jns.2017.07.015</mixed-citation><mixed-citation xml:lang="en">Boulouis G., Charidimou A., Pasi M., Roongpiboonsopit D., Xiong L., Auriel E. et al. Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: Comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers. J. Neurol. Sci. 2017;380:64–67. https://doi.org/10.1016/j.jns.2017.07.015</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Doubal F.N., MacLullich A.M., Ferguson K.J., Dennis M.S., Wardlaw J.M. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450–454. https://doi.org/10.1161/STROKEAHA.109.564914.</mixed-citation><mixed-citation xml:lang="en">Doubal F.N., MacLullich A.M., Ferguson K.J., Dennis M.S., Wardlaw J.M. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450–454. https://doi.org/10.1161/STROKEAHA.109.564914.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Ballerini L., Lovreglio R., Valdés Hernández M.D.C., Ramirez J., MacIntosh B.J., Black S.E. et al. Perivascular Spaces Segmentation in Brain MRI Using Optimal 3D Filtering. Sci. Rep. 2018;8(1):2132. https://doi.org/10.1038/s41598–018–19781–5</mixed-citation><mixed-citation xml:lang="en">Ballerini L., Lovreglio R., Valdés Hernández M.D.C., Ramirez J., MacIntosh B.J., Black S.E. et al. Perivascular Spaces Segmentation in Brain MRI Using Optimal 3D Filtering. Sci. Rep. 2018;8(1):2132. https://doi.org/10.1038/s41598–018–19781–5</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Charidimou A., Boulouis G., Haley K., Auriel E., van Etten E.S., Fotiadis P. et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2016;86(6):505–511. https://doi.org/10.1212/WNL.0000000000002362</mixed-citation><mixed-citation xml:lang="en">Charidimou A., Boulouis G., Haley K., Auriel E., van Etten E.S., Fotiadis P. et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2016;86(6):505–511. https://doi.org/10.1212/WNL.0000000000002362</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Гнедовская Е.В., Добрынина Л.А., Кротенкова М.В., Сергеева А.Н. МРТ в оценке прогрессирования церебральной микроангиопатии. Анналы клинической и экспериментальной неврологии. 2018;12(1):61–68. https://doi.org/10.25692/ACEN.2018.1.9</mixed-citation><mixed-citation xml:lang="en">Gnedovskaya E.V., Dobrynina L.A., Krotenkova M.V., Sergeeva A.N. [MRI in the assessment of cerebral small vessel disease. Annals of clinical and experimental neurology. 2018;12(1):61–68. (In Russian). https://doi.org/10.25692/ACEN.2018.1.9</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Biﬃ A., Greenberg S.M. Cerebral amyloid angiopathy: a systematic review. J. Clin. Neurol. 2011;7(1):1–9. https://doi.org/10.3988/jcn.2011.7.1.1</mixed-citation><mixed-citation xml:lang="en">Biﬃ A., Greenberg S.M. Cerebral amyloid angiopathy: a systematic review. J. Clin. Neurol. 2011;7(1):1–9. https://doi.org/10.3988/jcn.2011.7.1.1</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma R., Dearaugo S., Infeld B., O’Sullivan R., Gerraty R.P. Cerebral amyloid angiopathy: Review of clinico–radiological features and mimics. J. Med. Imaging Radiat Oncol. [published online ahead of print, 2018 Mar 31. https://doi.org/10.1111/1754–9485.12726</mixed-citation><mixed-citation xml:lang="en">Sharma R., Dearaugo S., Infeld B., O’Sullivan R., Gerraty R.P. Cerebral amyloid angiopathy: Review of clinico–radiological features and mimics. J. Med. Imaging Radiat Oncol. [published online ahead of print, 2018 Mar 31. https://doi.org/10.1111/1754–9485.12726</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Gurol M.E., Viswanathan A., Gidicsin C., Hedden T., Martinez– Ramires S., Dumas A. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann. Neurol. 2013;73(4):529–536. https://doi.org/10.1002/ana.23830</mixed-citation><mixed-citation xml:lang="en">Gurol M.E., Viswanathan A., Gidicsin C., Hedden T., Martinez– Ramires S., Dumas A. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann. Neurol. 2013;73(4):529–536. https://doi.org/10.1002/ana.23830</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am. J. Roentgenol. 1987;149(2):351–356. https://doi.org/10.2214/ajr.149.2.351</mixed-citation><mixed-citation xml:lang="en">Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am. J. Roentgenol. 1987;149(2):351–356. https://doi.org/10.2214/ajr.149.2.351</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu Y.C., Chabriat H., Godin O., Dufouil C., Rosand J., Greenberg S.M. Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J. Neurol. 2012;259(3):530–536. https://doi.org/10.1007/s00415–011–6218–3</mixed-citation><mixed-citation xml:lang="en">Zhu Y.C., Chabriat H., Godin O., Dufouil C., Rosand J., Greenberg S.M. Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J. Neurol. 2012;259(3):530–536. https://doi.org/10.1007/s00415–011–6218–3</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
